PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of SecuritiesGlobe Newswire•31/08/2026•23:03 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?
